September 2020 Briefing – Pulmonology
Here are what the editors at HealthDay consider to be the most important developments in Pulmonology for September 2020. This roundup includes the latest...
Bronchitis in Early Childhood Linked to Later Lung Disease
Lung diseases occurring later in life more likely to be asthma, pneumonia rather than chronic bronchitis
No Moderna COVID-19 Vaccine Expected Until Next Spring
Company will not be ready to seek U.S. approval for the vaccine until at least late January
Review: Children, Teens Have Lower Susceptibility to SARS-CoV-2
Most studies consistent with lower seroprevalence for children versus adults; similar for teens, adults
GI Complications More Common in Critically Ill With COVID-19
More transaminitis, severe ileus, bowel ischemia observed versus patients with non-COVID-19 acute respiratory distress
Atezolizumab Prolongs Survival in NSCLC With PD-L1 Expression
Overall survival longer than for chemotherapy in metastatic NSCLC with high PD-L1 expression
Number, Proportion of Pediatric COVID-19 Cases Rising in the U.S.
Less than 3 percent of reported cases were pediatric in April versus 12 to 15.9 percent in last eight weeks
In-Hospital Cardiac Arrest Common in Critically Ill With COVID-19
About half received cardiopulmonary resuscitation; only 12 percent receiving CPR survived to discharge
Hospital Admissions Not Related to COVID-19 Fell in Early 2020
From February to April 2020, drop >20 percent observed for all primary admission diagnoses
Current Trends in COVID-19 Reported for U.S. Youth
Incidence of COVID-19 higher in teenagers than children during May to September 2020
